化合物 AG14361|T6339|TargetMol

AG14361
328543-09-5

￥356 1mg 起订

￥987 5mg 起订

￥1970 10mg 起订

上海更新日期：2024-12-12

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 化合物 AG14361

英文名称：: AG14361

CAS号：: 328543-09-5

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 99.73%

产品类别：: 抑制剂

货号：: T6339

Product Introduction

Bioactivity

名称	AG14361
描述	AG14361 is an effective inhibitor of PARP1 (Ki<5 nM).
细胞实验	LoVo and SW620 colorectal cancer cells and A549 non–small-cell lung carcinoma cells are maintained in RPMI-1640 medium containing 10% fetal calf serum. Cell growth inhibition is estimated in exponentially growing LoVo, A549, and SW620 cells in 96-well plates. Cells are exposed to AG14361 (0–20 μM) alone or in the presence of 400 μM temozolomide. After 5 days of culture, these cells are fixed with 10% trichloroacetic acid and stained with sulforhodamine B. The concentration of temozolomide, topotecan, and AG14361 alone or in combination that inhibits growth by 50% (GI50) is calculated from computer-generated curves. Recovery from potentially lethal damage is measured in confluent LoVo cell cultures arrested in G1 phase to mimic the radiation-resistant quiescent cell population in tumors. Such cells are exposed to 8 Gy of γ-irradiation and then harvested and plated for colony formation assay immediately or maintained as growth-arrested confluent cultures for a 4-hour or 24-hour recovery period before harvesting and plating for the colony formation assay. Where indicated, 0.4 μM AG14361 is added 30 minutes before irradiation and is present in the recovery incubation. (Only for Reference)
激酶实验	PARP-1 Activity Assays: The activity of full-length recombinant human PARP-1 is measured in a reaction mixture containing 20 nM PARP-1, 500 μM NAD+ plus [32P]NAD+ (0.1–0.3 μCi per reaction mixture), and activated calf thymus DNA (10 μg/mL) at 25oC; the reaction is terminated after 4 minutes by adding ice-cold 10% (wt/vol) trichloroacetic acid. The reaction product [32P]ADP-ribose incorporated into acid-insoluble material is deposited onto Whatman GF/C glass fiber filters with a Bio-Dot microfiltration apparatus and quantified with a PhosphorImager. Inhibition of PARP-1 activity by AG14361 at 0–600 nM is measured, and the Ki for AG14361 is calculated by nonlinear regression analysis.
体外活性	在无毒剂量内,AG14361可提高伊立替康、x射线照射及替莫唑胺诱导的LoVo移植瘤生长延迟,提高2到3倍.在SW620移植瘤中, AG14361（10 mg/kg,i.p.）处理4小时以上可抑制75%以上的PARP-1活性.在携带LoVo移植瘤的小鼠体内,先以AG14361处理再进行统计学辐射,看显著提高对放射疗法的敏感性.在移植瘤中,AG14361可显著提高血流,故可能促进药物输送到移植瘤.
体内活性	AG14361（0.4 μM）对癌细胞基因表达或生长无影响,但可提高替莫唑胺和拓扑替康抗增殖活性,且抑制LoVo细胞从潜在的致命γ辐射损伤中恢复,抑制达73％。AG14361（0.4 μM）对基因表达无大幅影响。在A549细胞中, AG14361（0.4 μM）在17小时后对6800种基因表达均无影响。因此,尽管0.4 μM AG14361抑制85%以上细胞PARP-1 活性,但其不影响基因表达和细胞增殖。AG14361在更高浓度会影响基因表达,但是这种影响与PARP-1受抑制无关,因为在PARP-/-和PARP-1+/+细胞中,细胞增殖一样受影响。AG14361可增加喜树碱诱导DNA单链断裂的持久性。AG14361的效果比苯甲酰胺至少高1×103倍。AG14361对透性化SW620细胞（IC50：29 nM）和完整SW620细胞（IC50：14 nM）有抑制作用。AG14361对细胞生长的抑制作用与PARP-1抑制无关,因为在比GI50浓度低很多时(≤1 μM),对PARP-1也有最大抑制效果。
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 15 mg/mL (46.82 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : < 1 mg/mL (insoluble or slightly soluble)
关键字	inhibit \| PARP \| Inhibitor \| AG14361 \| poly ADP ribose polymerase
相关产品	VPC-70063 \| Rucaparib \| Niraparib \| XAV-939 \| Olaparib \| 3-Aminobenzamide \| Benzamide \| OUL35 \| 3-Methoxybenzamide \| Picolinamide \| 4'-Methoxychalcone \| EB-47
相关库	抑制剂库 \| 抗癌活性化合物库 \| 经典已知活性库 \| 抗癌化合物库 \| 已知活性化合物库 \| 抗心血管疾病化合物库 \| 高选择性抑制剂库 \| 抗衰老化合物库 \| 临床前化合物库 \| 抗前列腺癌化合物库

AG-14361|||AG 14361|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务